4^th International Conference on Gastroenterology July 20-22, 2015 Florida, USA

My main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.

My main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.

Steven Teich, MD, is the Surgical Director of the Neonatal Intensive Care Unit at Nationwide Children’s Hospital and a Clinical Associate Professor of Surgery at The Ohio State University College of Medicine. Dr. Teich coordinates the development of clinical pathways for pediatric surgery. He also serves as the Surgical Director of the Bariatric Surgery Program at Nationwide Children’s Hospital. Dr. Teich is currently the Vice President of the Medical Staff at Nationwide Children’s Hospital

Surgery

Dr. Lichtenstein is currently an Associate Professor of Medicine and Director of Endoscopy at Boston Medical Center, Boston University School of Medicine. He also has staff appointments in the section of Gastroenterology at Boston VA Medical Centers in Jamaica Plains and West Roxbury, Massachusetts and Quincy Medical Center in Quincy, Massachusetts. The recipient of numerous awards, Dr. Lichtenstein has been included in several Who’s Who directories and selected by his peers for inclusion in The Best Doctors in America database, Guide toAmerica’s Top Doctors, and Boston Magazine’s “Best Doctors of Boston”. He has served on the Research, Standards of Practice, International, and Web Application Committees for the American Society of Gastrointestinal Endoscopy (ASGE). His professional society memberships include the American Gastroenterological Association, the American Society of Gastrointestinal Endoscopy and theAmerican College of Gastroenterology, among others. Dr. Lichtenstein is a past President of the New England Endoscopy Society. In 2008, he chaired the ERCP Section of the ASGE’s Annual Scientific Program for Digestive Disease Week.

Pancreatic and biliary tract disorders; Gastrointestinal hemorrhage; Acid-peptic disorders; Diagnostic and therapeutic endoscopy

Jose M. Nieto, D.O. completed his fellowship in gastroenterology and hepatology at the University of California, Los Angeles, and completed an additional year of advanced endoscopy training in Interventional Pancreatobiliary Endoscopy and Endoscopic Ultrasound at UCLA Medical Center. He joins us from Orlando Florida, where he was on the clinical faculty staff at Florida Hospital Cancer Institute, and was essential in the development of the pancreatic disease and cancer program there.

pancreatic disease

Dr. Wan received her B.S. from the School of Pharmacy at Taipei Medical College in Taiwan in 1979. She received her M.S. in 1981 and her Ph.D. in 1983 in Experimental Pathology from Drexel University. Following, she obtained a fellowship from NIH to study molecular biology of the liver before she became a faculty member in the Pathology Department at Harbor UCLA in 1989. She became a Full Professor in 2001. In 2003, Dr. Wan was recruited by the Pharmacology Department at University of Kansas Medical Center. In 2007, Dr. Wan was named the Director of the Liver Center and the Leader of the Cancer Biology Program at the Cancer Center at KUMC. After nine years of service at KUMC, Dr. Wan has joined the Department of Medical Pathology & Laboratory Medicine at the University of California, Davis Medical Center in 2012. In recognition of her accomplishments in the field of liver research, Dr. Wan received the Distinguished Women in Research Award honored by California Councilwoman Janice Hahn and Congresswoman Jane Harman. She also received the Richard Weitzman Award at UCLA and Investigator Research Award at KUMC. In addition to her research, Dr. Wan is actively involved in service at national and institutional levels. She was an NIH study section standing member for from 2000-2005 and continued served as an ad hoc member from 2005-2008. In 2009, she began serving on the Xenobiotic and Nutrient Disposition and Action Study Section for another four years. From 2006-2007, she was the President of Central State Society of Toxicology. She is also an editorial member for many journals. Dr. Wan is involved in teaching medical students, residents, research and clinical fellows, as well as graduate and undergraduate students. She also mentors junior faculty. She has formally mentored 13 junior faculty members, most of which have received their first NIH RO1 grant in recent years. Over the years, she has mentored 40 Ph.D. and/or M.D. post-doctoral fellows, 7 visiting scholars, and more than 30 students. As mentioned above, her outstanding contribution in mentoring has been recognized by receiving the Joy McCann Professorship in 2007 and the SIG Elsevier Mentoring Award from the Society of Toxicology in 2009.

Study the effects of alcohol, hepatitis virus, and high fat diets on the liver. Study the pathophysiology of the liver with specific interests in understanding the mechanism underlying the development of metabolic syndromes, fatty liver, fibrosis, cirrhosis, and liver cancer. The goal is to identify potential therapeutic targets in the prevention and treatment of liver disease. Study the role of vitamin A in liver health and disease.

Dr. Ira-Ida Skvortsova studied medicine at the Altai State Medical University (Russia) from 1981-1987. She completed her oncology residency at the same University, as well as an ESMO research fellowship at Innsbruck Medical University (Austria). Since 2000, Dr. Skvortsova is a head of the Laboratory for Translational Research in Radiation Oncology (Dept. of Therapeutic Radiology and Oncology, Innsbruck Medical University).

Dr. Ira-Ida Skvortsova research interests include Mechanisms of the primary and secondary resistance to anti-cancer treatment approaches (chemotherapy, targeted therapeutics, radiation therapy), Signal transduction pathways involved in carcinogenesis and anti-cancer response, Cancer stem cells and their role in local and distant tumor recurrences after treatment, Proteome approach in biomarker development.

Dr. Arya is Director of Gastroenterology at Wyckoff Heights Medical Center in Brooklyn, New York. He is an assistant clinical professor at Weill Cornell Medical College. He is certified by the American Board of Internal Medicine in Gastroenterology. He is a fellow of American Gastroenterology Association, the American College of Gastroenterology and the American College of Physicians. Dr. Arya is an attending physician at North Shore University Hospital at the Long Island Jewish Health System, and a clinical educator at Brooklyn Hospital

Michel Kahaleh, MD, AGAF, FACG, FASGE is the Chief of Endoscopy at Weill Cornell Medical College. Trained in Erasme Hospital, University of Brussels, he led the Pancreatico-Biliary team of endoscopists at the University of Virginia before joining Well Cornell Medical College in July 2011. He is a world renowned endoscopist boarded in both Europe and the United States. He is fluent is French, Spanish and Arabic. The adjunct use of both Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasonography (EUS) has permitted him and his team to successfully treat pancreatic collections and perform newly described procedures that have had a major impact on patient management. With over 100 publications, Dr. Kahaleh's research has primarily focused on interventional endoscopy. He continually serves as a primary investigator on many clinical trials; including those that involve the use of new devices to diagnose and treat biliary and pancreatic diseases. A major focus of his research is on preventing and treating complications of advanced endoscopic procedures. He is actively analyzing the efficacy of metallic stents in both benign and malignant diseases. Another area of investigation for Dr. Kahaleh is understanding and preventing biliary and pancreatic cancer. The objective is to develop new diagnostic techniques for reducing the mortality associated with those cancers, by detecting them earlier and treating them using novel therapies such as laser therapy, photodynamic therapy and radiofrequency ablation.

I lead the UCL Applied Biomedical Engineering Group, based in Division of Medicine. The group is affiliated to the Research Department of Metabolism and Experimental Therapeutics and forms part of the Centre for Cardiovascular Biology and Medicine.

My research interests are centered on the application of biomedical engineering to provide healthcare solutions for debilitating conditions, which contribute to the UCL Grand Challenge of Human Wellbeing. To enable this, we have cross-disciplinary research collaborations with other UCL groups in the Faculties of Engineering, Life Sciences, Mathematical & Physical Sciences, and Medical Sciences, as well as clinical and surgical collaborations at the affiliated University College London Hospital. The group works closely with the UCL Translational Research Office and UCL Business to facilitate clinical translation and commercialization of our exciting and innovative technology.

Rāzvan Arsenescu, MD, PhD, is Associate Professor in the Division of Gastroenterology, Hepatology, and Nutrition, and Director of the Inflammatory Bowel Diseases Center at The Ohio State University in Columbus. He received his MD from University of Medicine and Pharmacy Targu Mures, Romania, and PhD in immunology from the University of Kentucky in Lexington. Dr Arsenescu completed his residency in gastroenterology at University Iowa Hospitals and Clinics, and internal medicine at Nassau CO Medical Center. He has authored articles that have been published in Journal of Immunology, Gastrointestinal Endoscopy, and Inflammatory Bowel Diseases. Dr Arsenescu is a member of the Crohn's and Colitis Foundation of America, American Gastroenterological Association, American Society for Gastroenterological Endoscopy, and Society for Mucosal Immunology.

Dr. Manoop S.Bhutani is currently working as Professor of Medicine and Experimental Diagnostic Imaging in the Department of Gastroenterology, Hepatology and Nutrition at the University of Texas MD Anderson Cancer,Texas, USA. He is also Director of Endoscopic Research and Development at The University of Texas MD Anderson Cancer Center. Eminent Scientist of the Year -2008 in Gastroenterology/Endoscopy-World Scientist Forum.

Gastroenterology, Endoscopy

Robert H. Getzenberg, Ph.D. is the Director of Strategic Clinical Affairs at GTx Inc. Previously, he was Director of Research of the James Buchanan Brady Urological Institute and Professor of Urology at the Johns Hopkins University School of Medicine. Dr. Getzenberg received his Ph.D. from the Johns Hopkins University School of Medicine in 1992. Dr. Getzenberg then completed a post-doctoral fellowship at the Yale University School of Medicine. Dr. Getzenberg is the recipient of a number of awards including the 2000 University of Pittsburgh chancellor’s Distinguished Research Award and was selected as one of the “40 under 40” by Pittsburgh Magazine. Dr. Getzenberg has been the recipient of a number of grants from the National institutes of Health and other agencies and foundations. Dr. Getzenberg has served in a number of international leadership positions and has authored a large number of manuscripts and book chapters in the field.

Dr. Lipkin is a board certified Medical Geneticist with a focus on genetic testing for gastrointestinal diseases, including the Lynch Syndrome, Familial Adenomatous Polyposis, Hemochromatosis and Hereditary Pancreatic Cancer among others. He is an authority on cancer genetic syndromes, with a particular emphasis on hereditary Gastrointestinal cancer syndromes. He is the author of MAPP-MMR, a bioinformatic program that is used to interpret whether Lynch syndrome missense variants are deleterious muations or benign polymorphisms. He practices at Weill Medical College of Cornell University and New York-Presbyterian Hospital. He trained in Internal Medicince at Duke University and Medical Genetics at the National Human Genome Research Institute.

Scott T. Tagawa, MD was appointed to the faculty of Weill Cornell Medical College in April, 2007 as Assistant Professor of Medicine and Urology and Assistant Attending Physician in the Division of Hematology and Medical Oncology. He has joined the Genitourinary Oncology Program within the Solid Tumor Service in the Division of Hematology and Medical Oncology. After earning his BS from Georgetown University in 1993, Dr. Tagawa received his MD at the University of Southern California School of Medicine in 1998. After completing his Internship and Residency training there, he was Chief Resident from 2001-2002 and underwent fellowship training in Hematology and Medical Oncology from 2002-2005, being appointed Chief Fellow from 2003-2005. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center he took the lead in developing genitourinary clinical trials. His research has involved clinical and translational investigations in genitourinary tumors and thrombosis in malignancy. As the Medical Director of the Genitourinary Oncology Research Program, he leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer.

Vidant Medical Center, USA

Gastroenterology